These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9284787)

  • 21. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.
    Gomez PS; Parks S; Ries R; Tran TC; Gomez PF; Press RD
    Nat Genet; 1999 Nov; 23(3):272. PubMed ID: 10545944
    [No Abstract]   [Full Text] [Related]  

  • 22. Can large cell change and high proliferative activity predict hepatocellular carcinoma in patients with hereditary hemochromatosis?
    Fracanzani AL; Borzio M; Roncalli M; Derenzini M; Trerè D; Mattioli M; Taioli E; Fiorelli G; Fargion S
    Am J Gastroenterol; 2000 Oct; 95(10):2940-5. PubMed ID: 11051372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical usefulness of the detection of mutations of the HFE gene in hemochromatosis].
    Oliva R; Sánchez M; Bruguera M; Rodés J
    Gastroenterol Hepatol; 2000 Nov; 23(9):433-5. PubMed ID: 11126040
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatocellular carcinoma in a patient with hereditary hemochromatosis and noncirrhotic liver. A case report.
    Köhler HH; Höhler T; Küsel U; Kirkpatrick CJ; Schirmacher P
    Pathol Res Pract; 1999; 195(7):509-13. PubMed ID: 10448668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hemochromatosis gene.
    Leber BF
    Clin Invest Med; 2000 Dec; 23(6):382-6. PubMed ID: 11152407
    [No Abstract]   [Full Text] [Related]  

  • 26. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
    Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
    Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of genotyping in diagnosis of genetic haemochromatosis.
    Crawford DH; Fletcher LM
    J Gastroenterol Hepatol; 1999 May; 14(5):401-2. PubMed ID: 10355500
    [No Abstract]   [Full Text] [Related]  

  • 28. Two novel polymorphisms (E277K and V212V) in the haemochromatosis gene HFE.
    Bradbury R; Fagan E; Payne SJ
    Hum Mutat; 2000 Jan; 15(1):120. PubMed ID: 10612845
    [No Abstract]   [Full Text] [Related]  

  • 29. Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis.
    Datz C; Lalloz MR; Vogel W; Graziadei I; Hackl F; Vautier G; Layton DM; Maier-Dobersberger T; Ferenci P; Penner E; Sandhofer F; Bomford A; Paulweber B
    J Hepatol; 1997 Nov; 27(5):773-9. PubMed ID: 9382962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High frequency of the H63D mutation of the hemochromatosis gene (HFE) in malignant gliomas.
    Martinez di Montemuros F; Tavazzi D; Salsano E; Piepoli T; Pollo B; Fiorelli G; Finocchiaro G
    Neurology; 2001 Oct; 57(7):1342. PubMed ID: 11591868
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study.
    Salonen JT; Tuomainen TP; Kontula K
    BMJ; 2000 Jun; 320(7251):1706-7. PubMed ID: 10864547
    [No Abstract]   [Full Text] [Related]  

  • 32. [HFE gene mutations and risk of hepatocellular carcinoma].
    Solís Herruzo JA; Solís Muñoz P
    Rev Esp Enferm Dig; 2007 Jul; 99(7):369-75. PubMed ID: 17973579
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical haemochromatosis in HFE mutation carriers.
    Cox T; Rochette J; Camaschella C; Walker A; Robson K
    Lancet; 2002 Aug; 360(9330):412; discussion 413-4. PubMed ID: 12241804
    [No Abstract]   [Full Text] [Related]  

  • 34. Incidence of liver disease in people with HFE mutations.
    Willis G; Wimperis JZ; Lonsdale R; Fellows IW; Watson MA; Skipper LM; Jennings BA
    Gut; 2000 Mar; 46(3):401-4. PubMed ID: 10673304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic screening for common mutations: lessons from hereditary hemochromatosis.
    Njajou OT; Alizadeh BZ; van Duijn CM
    Eur J Epidemiol; 2003; 18(1):3-4. PubMed ID: 12705616
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemochromatosis after the gene discovery: revisiting the diagnostic strategy.
    Brissot P; Moirand R; Guyader D; Loréal O; Turlin B; Deugnier Y
    J Hepatol; 1998; 28 Suppl 1():14-8. PubMed ID: 9575443
    [No Abstract]   [Full Text] [Related]  

  • 37. Haemochromatosis gene C282Y homozygotes in an elderly male population.
    Willis G; Wimperis JZ; Smith KC; Fellows IW; Jennings BA
    Lancet; 1999 Jul; 354(9174):221-2. PubMed ID: 10421310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HFE genotyping by amplification refractory mutation system-denaturing HPLC.
    Pissard S; Huynh LT; Martin J; Goossens M
    Clin Chem; 2002 May; 48(5):769-72. PubMed ID: 11978606
    [No Abstract]   [Full Text] [Related]  

  • 39. Haemochromatosis: strike while the iron is hot.
    Cox T
    Nat Genet; 1996 Aug; 13(4):386-8. PubMed ID: 8696327
    [No Abstract]   [Full Text] [Related]  

  • 40. Hemochromatosis-related mutation detection.
    Merryweather-Clarke AT; Shearman JD; Robson KJ; Pointon JJ; Liu YT; Bomford A; Dooley J; Walker AP; Worwood M
    Blood; 1998 Apr; 91(7):2620-1. PubMed ID: 9516166
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.